Another cure from cancer. Again (No 3)!

I have found a good candidate to be a Black Swan in onology (taken from here):

"One company that is trying to break this mold of oncology drug development is Immunocellular Therapeutics, which is developing ways to stimulate the body's own immune system simultaneously against multiple targets, a page stolen from the vaccine world. Each tumor cell has hundreds of antigens that are expressed on the cell surface, however most are also shared with normal cells. A few antigens are different on these cancer cells, and while other companies are pursuing a strategy of targeting only one of these many antigens, such as Dendreon (DNDN), IMUC's approach is to target several antigens simultaneously. Going back to the problem of blocking the traffic, IMUC's approach is to close as many avenues as possible so traffic really comes to a halt, which makes it easier to treat the cancerous cells."

Well, Dendreon failed but there still exists the possibility for the improvement of the immunotherapeutic approach. And do you know what? In case if the approach will not be found so efficient to become a Black Swan it can be efficiently used and profited by Big Pharma (to become a Dirty Swan). The immunotherapy can be sufficiently overcomplicated to be able to generate tremendous costs for the treatment – exactly what pharma industry is constantly looking for.